Over the past decade, the incidence of non-Hodgkin's lymphoma has been rising. At the same time, the benefits of extensive research in tumor immunology and molecular biology have radically altered our understanding of lymphoma biology. New therapeutic agents have advanced rapidly from the laboratory to the bedside.
In Malignant Lymphomas, Dr. Grossbard has assembled an expert group of 48 colleagues to address the disease group by type-indolent B-cell lymphoma, diffuse large cell lymphomas, Burkitt's/high-grade non-Hodgkin's lymphoma - as well as the key therapies of chemotherapy, monoclonal antibody, radiation, vaccine, hematopoietic stem cell transplants, and more.
This volume on lymphoma is designed to summarize current knowledge on the pathology, epidemiology, molecular biology, presentation, and management of patients with both non-Hodgkin's lymphoma and Hodgkin's disease. It is an essential reference not only for the specialist in lymphoma but also for the general oncologist and all those who manage these diseases on a daily basis.
• Covers screening and diagnosis • Presents contemporary data designed to stimulate further discussion and research • Includes contributions representing medical, surgical, and radiation oncology and related disciplines • More than 200 color clinical photographs, photomicrographs, karyotypes, radiographs, tables, and algorithms illustrate the manifestation of the disease • Images from the CD-ROM can be downloaded for lectures and presentations